1. Home
  2. EYPT vs ADSE Comparison

EYPT vs ADSE Comparison

Compare EYPT & ADSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • ADSE
  • Stock Information
  • Founded
  • EYPT 1987
  • ADSE 1980
  • Country
  • EYPT United States
  • ADSE Ireland
  • Employees
  • EYPT N/A
  • ADSE N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • ADSE Industrial Specialties
  • Sector
  • EYPT Industrials
  • ADSE Consumer Discretionary
  • Exchange
  • EYPT Nasdaq
  • ADSE Nasdaq
  • Market Cap
  • EYPT 741.0M
  • ADSE 644.4M
  • IPO Year
  • EYPT 2005
  • ADSE N/A
  • Fundamental
  • Price
  • EYPT $11.09
  • ADSE $11.75
  • Analyst Decision
  • EYPT Strong Buy
  • ADSE
  • Analyst Count
  • EYPT 7
  • ADSE 0
  • Target Price
  • EYPT $24.29
  • ADSE N/A
  • AVG Volume (30 Days)
  • EYPT 643.4K
  • ADSE 76.3K
  • Earning Date
  • EYPT 08-06-2025
  • ADSE 09-11-2025
  • Dividend Yield
  • EYPT N/A
  • ADSE N/A
  • EPS Growth
  • EYPT N/A
  • ADSE N/A
  • EPS
  • EYPT N/A
  • ADSE N/A
  • Revenue
  • EYPT $51,898,000.00
  • ADSE $113,896,884.00
  • Revenue This Year
  • EYPT N/A
  • ADSE $219.58
  • Revenue Next Year
  • EYPT N/A
  • ADSE N/A
  • P/E Ratio
  • EYPT N/A
  • ADSE N/A
  • Revenue Growth
  • EYPT 2.99
  • ADSE 2.45
  • 52 Week Low
  • EYPT $3.91
  • ADSE $9.00
  • 52 Week High
  • EYPT $13.99
  • ADSE $16.35
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 61.85
  • ADSE 51.39
  • Support Level
  • EYPT $10.22
  • ADSE $10.56
  • Resistance Level
  • EYPT $11.28
  • ADSE $11.80
  • Average True Range (ATR)
  • EYPT 0.71
  • ADSE 0.88
  • MACD
  • EYPT 0.04
  • ADSE 0.03
  • Stochastic Oscillator
  • EYPT 89.89
  • ADSE 47.79

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About ADSE ADS-TEC ENERGY PLC

ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services that enable the customer to control and manage the system. ADSE generates revenue mainly through the sale of its products, services, and Big-LinX. Geographically, it derives a majority of its revenue from Germany.

Share on Social Networks: